StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Integrated BioPharma's price to sales ratio was 0.1× on Oct 19, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.1× to 0.5×, with a median of 0.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.1×−0.1
2025Dec 31, 20250.2×+0.0
2024Dec 31, 20240.2×+0.0
2023Dec 29, 20230.1×−0.0
2022Dec 30, 20220.2×−0.3
2021Dec 31, 20210.5×+0.1
2020Dec 31, 20200.4×+0.2
2019Dec 31, 20190.1×+0.0
2018Dec 31, 20180.1×+0.0
2017Dec 29, 20170.1×−0.0
2016Dec 30, 20160.1×+0.1
2015Dec 31, 20150.1×−0.0
2014Dec 31, 20140.1×−0.1
2013Dec 31, 20130.1×+0.0
2012Dec 31, 20120.1×+0.1
2011Dec 30, 20110.0×–

More Integrated BioPharma figures

See a number that looks wrong?